Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Allylestrenol

    Client Email Product

    Allylestrenol

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    6
    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    3
    API REF. PRICE (USD / KG)
    1,484

    API Market Place

    2
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    1
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    43
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Organon To Report First Quarter 2024 Results and Host Conference Call
    Organon To Report First Quarter 2024 Results and Host Conference Call

    https://www.businesswire.com/news/home/20240408210237/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share
    Phase 3 Comparative Clinical Study of Prolia® and Xgeva Met Primary Endpoints
    Phase 3 Comparative Clinical Study of Prolia® and Xgeva Met Primary Endpoints

    https://www.businesswire.com/news/home/20240408963530/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share
    New York attorney general urges stronger safety warning on asthma drug Singulair
    New York attorney general urges stronger safety warning on asthma drug Singulair

    https://www.reuters.com/business/healthcare-pharmaceuticals/new-york-attorney-general-urges-stronger-safety-warning-asthma-drug-singulair-2024-02-23/

    REUTERS
    23 Feb 2024
    Share Share
    Organon Launches Programs and Listening Tour as Part of
    Organon Launches Programs and Listening Tour as Part of "Her Plan Is Her Power"

    https://www.accesswire.com/viewarticle.aspx?id=835070&lang=en

    ACCESSWIRE
    20 Feb 2024
    Share Share
    Organon Announces HADLIMA Has Been Selected by the US Department of VA
    Organon Announces HADLIMA Has Been Selected by the US Department of VA

    https://www.businesswire.com/news/home/20240220492029/en

    BUSINESSWIRE
    20 Feb 2024
    Share Share
    Organon's Humira biosimilar gets exclusive spot on VA formulary
    Organon's Humira biosimilar gets exclusive spot on VA formulary

    https://endpts.com/organons-humira-biosimilar-gets-exclusive-spot-on-va-formulary/

    ENDPTS
    16 Feb 2024
    Share Share
    Organon Co earnings beat by $0.09, revenue topped estimates
    Organon Co earnings beat by $0.09, revenue topped estimates

    https://in.investing.com/news/organon-co-earnings-beat-by-009-revenue-topped-estimates-4020664

    PRESS RELEASE
    15 Feb 2024
    Share Share
    Organon Reports Results for the Fourth Quarter and Full Year Ended December 31
    Organon Reports Results for the Fourth Quarter and Full Year Ended December 31

    https://www.businesswire.com/news/home/20240215838725/en

    BUSINESSWIRE
    15 Feb 2024
    Share Share
    Organon shelves contraceptive with 'natural' estrogen
    Organon shelves contraceptive with 'natural' estrogen

    https://endpts.com/organon-shelves-contraceptive-with-natural-estrogen/

    Nicole DeFeudis ENDPTS
    13 Feb 2024
    Share Share
    Organon To Report Fourth Quarter and Full Year Results and Host Conference Call
    Organon To Report Fourth Quarter and Full Year Results and Host Conference Call

    https://www.businesswire.com/news/home/20240201504170/en

    BUSINESSWIRE
    01 Feb 2024
    Share Share
    Organon’s XACIATO Vaginal Gel 2% Available Nationwide to Treat BV
    Organon’s XACIATO Vaginal Gel 2% Available Nationwide to Treat BV

    https://www.businesswire.com/news/home/20240110750811/en

    BUSINESSWIRE
    10 Jan 2024
    Share Share
    Organon affirms 2023 revenue
    Organon affirms 2023 revenue

    https://www.businesswire.com/news/home/20240108542270/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
    Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference

    https://www.businesswire.com/news/home/20231221445274/en

    BUSINESSWIRE
    21 Dec 2023
    Share Share
    Organon is taking over marketing of two Lilly meds in Europe
    Organon is taking over marketing of two Lilly meds in Europe

    https://www.fiercepharma.com/pharma/organon-pays-50m-upfront-pick-rights-pair-eli-lilly-migraine-meds-europe

    Fraiser Kansteiner FIERCE PHARMA
    18 Dec 2023
    Share Share
    Organon To Present at the Piper Sandler 35th Annual Healthcare Conference
    Organon To Present at the Piper Sandler 35th Annual Healthcare Conference

    https://www.businesswire.com/news/home/20231121549162/en

    BUSINESSWIRE
    21 Nov 2023
    Share Share
    Organon to work with White House on women's health research: CEO
    Organon to work with White House on women's health research: CEO

    https://www.fiercebiotech.com/biotech/organon-ceo-we-are-definitely-going-be-involved-white-house-womens-health-initiative

    Max Bayer FIERCE BIOTECH
    15 Nov 2023
    Share Share
    Samsung Bioepis & Organon Announce Acceptance of sBLA for Interchangeability Designation for HADLIMA
    Samsung Bioepis & Organon Announce Acceptance of sBLA for Interchangeability Designation for HADLIMA

    https://www.globenewswire.com//news-release/2023/11/07/2775667/0/en/Samsung-Bioepis-Organon-Announce-FDA-Acceptance-of-Supplemental-Biologics-License-Application-sBLA-for-Interchangeability-Designation-for-HADLIMA-adalimumab-bwwd-a-Biosimilar-to-Hu.html

    GLOBENEWSWIRE
    07 Nov 2023
    Share Share
    Organon Reports Results for the Third Quarter Ended September 30, 2023
    Organon Reports Results for the Third Quarter Ended September 30, 2023

    https://www.businesswire.com/news/home/20231102429565/en

    BUSINESSWIRE
    02 Nov 2023
    Share Share
    Organon and Sempre Health Announce Collaboration
    Organon and Sempre Health Announce Collaboration

    https://www.businesswire.com/news/home/20231101900583/en

    BUSINESSWIRE
    01 Nov 2023
    Share Share
    Organon Returns Ebopiprant to XOMA
    Organon Returns Ebopiprant to XOMA

    https://www.globenewswire.com//news-release/2023/10/27/2768722/0/en/Organon-Returns-Ebopiprant-to-XOMA.html

    GLOBENEWSWIRE
    27 Oct 2023
    Share Share
    Organon To Report Third Quarter Results and Host Conference on November 2, 2023
    Organon To Report Third Quarter Results and Host Conference on November 2, 2023

    https://www.businesswire.com/news/home/20231019256069/en

    BUSINESSWIRE
    19 Oct 2023
    Share Share
    Organon Recognized on Fortune’s 2023 Change the World List
    Organon Recognized on Fortune’s 2023 Change the World List

    https://www.businesswire.com/news/home/20230926715642/en

    BUSINESSWIRE
    27 Sep 2023
    Share Share
    Organon touts real-world win of its postpartum hemorrhage device
    Organon touts real-world win of its postpartum hemorrhage device

    https://www.fiercebiotech.com/medtech/organon-touts-real-world-success-its-jada-system-stopping-postpartum-hemorrhage

    Conor Hale FIERCE BIOTECH
    18 Sep 2023
    Share Share
    Organon Bolsters R&D Expertise with Two Leadership Appointments
    Organon Bolsters R&D Expertise with Two Leadership Appointments

    https://www.businesswire.com/news/home/20230905468265/en

    BUSINESSWIRE
    05 Sep 2023
    Share Share
    Organon Reports Results for the Second Quarter Ended June 30, 2023
    Organon Reports Results for the Second Quarter Ended June 30, 2023

    https://www.businesswire.com/news/home/20230808112874/en

    BUSINESSWIRE
    08 Aug 2023
    Share Share
    Samsung Bioepis & Organon Announce Results from Study of SB5 Humira Biosimilar
    Samsung Bioepis & Organon Announce Results from Study of SB5 Humira Biosimilar

    https://www.globenewswire.com/news-release/2023/08/01/2715628/0/en/Samsung-Bioepis-Organon-Announce-Topline-Results-from-Interchangeability-Study-of-SB5-Humira-Biosimilar.html

    GLOBENEWSWIRE
    01 Aug 2023
    Share Share
    Organon To Report Second Quarter Results and Host Conference on August 8, 2023
    Organon To Report Second Quarter Results and Host Conference on August 8, 2023

    https://www.businesswire.com/news/home/20230717231219/en

    BUSINESSWIRE
    17 Jul 2023
    Share Share
    Organon, Samsung launch copycat for arthritis drug Humira at 85% discount
    Organon, Samsung launch copycat for arthritis drug Humira at 85% discount

    https://www.reuters.com/business/healthcare-pharmaceuticals/organon-samsung-bioepis-launch-copycat-athritis-drug-humira-85-discount-2023-07-01/

    REUTERS
    03 Jul 2023
    Share Share
    Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA
    Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA

    https://www.businesswire.com/news/home/20230701610293/en

    BUSINESSWIRE
    01 Jul 2023
    Share Share
    Organon allies with Latin American bank to boost women's health
    Organon allies with Latin American bank to boost women's health

    https://www.fiercepharma.com/marketing/organon-teams-bank-fund-womens-health-initiatives-latin-america-caribbean

    Nick Paul Taylor FIERCE PHARMA
    14 Jun 2023
    Share Share
    Organon and CAF Launch First-of-Its-Kind Collaboration
    Organon and CAF Launch First-of-Its-Kind Collaboration

    https://www.businesswire.com/news/home/20230607005324/en

    BUSINESSWIRE
    07 Jun 2023
    Share Share
    Organon builds pipeline for women's health but can't do it alone
    Organon builds pipeline for women's health but can't do it alone

    https://www.fiercebiotech.com/biotech/1-rd-investment-female-specific-yet-organon-remains-set-discovering-holy-grail-womens

    Gabrielle Masson FIERCE BIOTECH
    16 Mar 2023
    Share Share
    Organon pledges $30M to improve contraceptive info
    Organon pledges $30M to improve contraceptive info

    https://www.fiercepharma.com/marketing/organon-pledges-30-million-improve-contraceptive-info-and-services-around-globe

    FIERCE PHARMA
    09 Mar 2023
    Share Share
    Organon doubles down on mission to prevent unplanned pregnancies
    Organon doubles down on mission to prevent unplanned pregnancies

    https://endpts.com/organon-doubles-down-on-mission-to-prevent-unplanned-pregnancies-with-30m-investment/

    Nicole DeFeudis ENDPTS
    08 Mar 2023
    Share Share
    Organon Launches “Her Plan is Her Power”
    Organon Launches “Her Plan is Her Power”

    https://www.businesswire.com/news/home/20230307005176/en

    BUSINESSWIRE
    07 Mar 2023
    Share Share
    Organon Reports Results for Fourth Quarter and Full Year Ended December 31, 2022
    Organon Reports Results for Fourth Quarter and Full Year Ended December 31, 2022

    https://www.businesswire.com/news/home/20230216005114/en

    BUSINESSWIRE
    16 Feb 2023
    Share Share
    Organon To Report Fourth Quarter and Full Year Results
    Organon To Report Fourth Quarter and Full Year Results

    https://www.businesswire.com/news/home/20230206005119/en

    BUSINESSWIRE
    06 Feb 2023
    Share Share
    Organon places bet on hysterectomy hardware maker Claria Medical
    Organon places bet on hysterectomy hardware maker Claria Medical

    https://www.fiercebiotech.com/medtech/womens-health-drugmaker-organon-places-bet-hysterectomy-hardware-developer-claria-medical

    Conor Hale FIERCE BIOTECH
    09 Jan 2023
    Share Share
    Organon Makes Strategic Investment in Claria Medical to Support Development
    Organon Makes Strategic Investment in Claria Medical to Support Development

    https://www.biospace.com/article/releases/organon-makes-strategic-investment-in-claria-medical-to-support-development-of-investigational-medical-device-for-minimally-invasive-hysterectomy/?s=79

    BIOSPACE
    05 Jan 2023
    Share Share
    Organon Reports Results for the Second Quarter Ended June 30, 2021
    Organon Reports Results for the Second Quarter Ended June 30, 2021

    https://www.businesswire.com/news/home/20210812005277/en

    BUSINESSWIRE
    12 Aug 2021
    Share Share
    Organon and ObsEva to collaborate on preterm labour treatment
    Organon and ObsEva to collaborate on preterm labour treatment

    http://www.pharmatimes.com/news/organon_and_obseva_to_collaborate_on_preterm_labour_treatment_1373670

    PHARMATIMES
    26 Jul 2021
    Share Share
    Organon and ObsEva to collaborate on preterm labour treatment
    Organon and ObsEva to collaborate on preterm labour treatment

    http://www.pharmatimes.com/news/organon_and_obseva_to_collaborate_on_preterm_labour_treatment_1373670

    PHARMATIMES
    26 Jul 2021
    Share Share
    Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer
    Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer

    https://www.businesswire.com/news/home/20210629005481/en

    BUSINESSWIRE
    29 Jun 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search